{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:41Z","timestamp":1787166101354,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901254"],"award-info":[{"award-number":["81901254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201538"],"award-info":[{"award-number":["82201538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Suzhou Health Talent Training","award":["GSWS2020105"],"award-info":[{"award-number":["GSWS2020105"]}]},{"name":"Project of Zhangjiagang Health Talent Training","award":["ZJGWSRC202004"],"award-info":[{"award-number":["ZJGWSRC202004"]}]},{"name":"Project of Zhangjiagang Science and Technology","award":["ZKS2017"],"award-info":[{"award-number":["ZKS2017"]}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["SWYY-088"],"award-info":[{"award-number":["SWYY-088"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018592","name":"\u201c333 Project\u201d of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018592","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qing Lan Project in Jiangsu Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11064-022-03796-6","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:04:06Z","timestamp":1667189046000},"page":"681-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Catalpol Ameliorates Oxidative Stress and Neuroinflammation after Traumatic Brain Injury in Rats"],"prefix":"10.1007","volume":"48","author":[{"given":"Haibo","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xugang","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baole","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"3796_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M (2020) Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin 104:213\u2013238. https:\/\/doi.org\/10.1016\/j.mcna.2019.11.001","journal-title":"Med Clin"},{"key":"3796_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pmr.2016.12.001","volume":"28","author":"KJ Dixon","year":"2017","unstructured":"Dixon KJ (2017) Pathophysiology of traumatic brain injury. Phys Med Rehabil Clin N Am 28:215\u2013225. https:\/\/doi.org\/10.1016\/j.pmr.2016.12.001","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"3796_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1474-4422(18)30494-0","volume":"18","author":"AG Kolias","year":"2019","unstructured":"Kolias AG, Rubiano AM, Figaji A, Servadei F, Hutchinson PJ (2019) Traumatic brain injury: global collaboration for a global challenge. Lancet Neurol 18:136\u2013137. https:\/\/doi.org\/10.1016\/S1474-4422(18)30494-0","journal-title":"Lancet Neurol"},{"key":"3796_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2174\/1871527317666180627120501","volume":"17","author":"N Khatri","year":"2018","unstructured":"Khatri N, Thakur M, Pareek V, Kumar S, Sharma S, Datusalia AK (2018) Oxidative stress: major threat in traumatic brain injury. CNS Neurol Disord Drug Targets 17:689\u2013695. https:\/\/doi.org\/10.2174\/1871527317666180627120501","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3796_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, McGeachy MJ, Bay\u0131r H, Clark RS, Loane DJ, Kochanek PM (2017) The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol 13:171\u2013191. https:\/\/doi.org\/10.1038\/nrneurol.2017.13","journal-title":"Nat Rev Neurol"},{"key":"3796_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s12035-014-8752-3","volume":"51","author":"P Abdul-Muneer","year":"2015","unstructured":"Abdul-Muneer P, Chandra N, Haorah J (2015) Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol 51:966\u2013979. https:\/\/doi.org\/10.1007\/s12035-014-8752-3","journal-title":"Mol Neurobiol"},{"key":"3796_CR7","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s12035-017-0456-z","volume":"55","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wang H (2018) Targeting the NF-E2-related factor 2 pathway: a novel strategy for traumatic brain injury. Mol Neurobiol 55:1773\u20131785. https:\/\/doi.org\/10.1007\/s12035-017-0456-z","journal-title":"Mol Neurobiol"},{"key":"3796_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3796_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01778-5","volume":"17","author":"WT O\u2019Brien","year":"2020","unstructured":"O\u2019Brien WT, Pham L, Symons GF, Monif M, Shultz SR, McDonald SJ (2020) The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation 17:1\u201312. https:\/\/doi.org\/10.1186\/s12974-020-01778-5","journal-title":"J Neuroinflammation"},{"key":"3796_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210\u2013215. https:\/\/doi.org\/10.1038\/nri2725","journal-title":"Nat Rev Immunol"},{"key":"3796_CR11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ars.2020.8257","volume":"36","author":"A Dominic","year":"2022","unstructured":"Dominic A, Le N-T, Takahashi M (2022) Loop between NLRP3 inflammasome and reactive oxygen species. Antioxid Redox Signal 36:784\u2013796. https:\/\/doi.org\/10.1089\/ars.2020.8257","journal-title":"Antioxid Redox Signal"},{"key":"3796_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2174\/0929867322666150114151720","volume":"22","author":"B Jiang","year":"2015","unstructured":"Jiang B, Shen R, Bi J, Tian X, Hinchliffe T, Xia Y (2015) Catalpol: a potential therapeutic for neurodegenerative diseases. Curr Med Chem 22:1278\u20131291. https:\/\/doi.org\/10.2174\/0929867322666150114151720","journal-title":"Curr Med Chem"},{"key":"3796_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jpba.2012.05.016","volume":"70","author":"Q Wang","year":"2012","unstructured":"Wang Q, Xing M, Chen W, Zhang J, Qi H, Xu X (2012) HPLC\u2013APCI\u2013MS\/MS method for the determination of catalpol in rat plasma and cerebrospinal fluid: application to an in vivo pharmacokinetic study. J Pharm Biomed Anal 70:337\u2013343. https:\/\/doi.org\/10.1016\/j.jpba.2012.05.016","journal-title":"J Pharm Biomed Anal"},{"key":"3796_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fnagi.2019.00316","volume":"11","author":"LY Wang","year":"2019","unstructured":"Wang LY, Yu X, Li XX, Zhao YN, Wang CY, Wang ZY, He ZY (2019) Catalpol exerts a neuroprotective effect in the MPTP mouse model of Parkinson\u2019s disease. Front Aging Neurosci 11:316. https:\/\/doi.org\/10.3389\/fnagi.2019.00316","journal-title":"Front Aging Neurosci"},{"key":"3796_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3892\/mmr.2015.4496","volume":"13","author":"JZ Huang","year":"2016","unstructured":"Huang JZ, Wu J, Xiang S, Sheng S, Jiang Y, Yang Z, Hua F (2016) Catalpol preserves neural function and attenuates the pathology of Alzheimer\u2019s disease in mice. Mol Med Rep 13:491\u2013496. https:\/\/doi.org\/10.3892\/mmr.2015.4496","journal-title":"Mol Med Rep"},{"key":"3796_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41398-021-01468-7","volume":"11","author":"YL Wang","year":"2021","unstructured":"Wang YL, Wu HR, Zhang SS, Xiao HL, Yu J, Ma YY, Zhang YD, Liu Q (2021) Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation. Transl Psychiatry 11:353. https:\/\/doi.org\/10.1038\/s41398-021-01468-7","journal-title":"Transl Psychiatry"},{"key":"3796_CR17","doi-asserted-by":"publisher","first-page":"5058609","DOI":"10.1155\/2017\/5058609","volume":"2017","author":"XW Zheng","year":"2017","unstructured":"Zheng XW, Yang WT, Chen S, Xu QQ, Shan CS, Zheng GQ, Ruan JC (2017) Neuroprotection of catalpol for experimental acute focal ischemic stroke: Preclinical evidence and possible mechanisms of antioxidation, anti-inflammation, and antiapoptosis. Oxid Med Cell Longev 2017:5058609. https:\/\/doi.org\/10.1155\/2017\/5058609","journal-title":"Oxid Med Cell Longev"},{"key":"3796_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0165-0270(91)90104-8","volume":"39","author":"CE Dixon","year":"1991","unstructured":"Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL (1991) A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 39:253\u2013262. https:\/\/doi.org\/10.1016\/0165-0270(91)90104-8","journal-title":"J Neurosci Methods"},{"key":"3796_CR19","doi-asserted-by":"publisher","first-page":"153300","DOI":"10.1016\/j.phymed.2020.153300","volume":"78","author":"H Wang","year":"2020","unstructured":"Wang H, Xu X, Yin Y, Yu S, Ren H, Xue Q, Xu X (2020) Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1alpha\/VEGF. Phytomedicine 78:153300. https:\/\/doi.org\/10.1016\/j.phymed.2020.153300","journal-title":"Phytomedicine"},{"key":"3796_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","volume":"117","author":"X Xu","year":"2018","unstructured":"Xu X, Yin D, Ren H, Gao W, Li F, Sun D, Wu Y, Zhou S, Lyu L, Yang M, Xiong J, Han L, Jiang R, Zhang J (2018) Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 117:15\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.016","journal-title":"Neurobiol Dis"},{"key":"3796_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2018.03.003","volume":"304","author":"H Ni","year":"2018","unstructured":"Ni H, Rui Q, Xu Y, Zhu J, Gao F, Dang B, Li D, Gao R, Chen G (2018) RACK1 upregulation induces neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats. Exp Neurol 304:102\u2013113. https:\/\/doi.org\/10.1016\/j.expneurol.2018.03.003","journal-title":"Exp Neurol"},{"key":"3796_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fncel.2018.00051","volume":"12","author":"Q Rui","year":"2018","unstructured":"Rui Q, Ni H, Gao F, Dang B, Li D, Gao R, Chen G (2018) LRRK2 contributes to secondary brain injury through a p38\/Drosha signaling pathway after traumatic brain injury in rats. Front Cell Neurosci 12:51. https:\/\/doi.org\/10.3389\/fncel.2018.00051","journal-title":"Front Cell Neurosci"},{"key":"3796_CR23","doi-asserted-by":"publisher","first-page":"113044","DOI":"10.1016\/j.expneurol.2019.113044","volume":"322","author":"Q Rui","year":"2019","unstructured":"Rui Q, Ni H, Lin X, Zhu X, Li D, Liu H, Chen G (2019) Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1\/MMP signaling pathway following traumatic brain injury. Exp Neurol 322:113044. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113044","journal-title":"Exp Neurol"},{"key":"3796_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fnins.2019.00674","volume":"13","author":"H Ni","year":"2019","unstructured":"Ni H, Rui Q, Lin X, Li D, Liu H, Chen G (2019) 2-BFI provides neuroprotection against inflammation and necroptosis in a rat model of traumatic brain injury. Front Neurosci 13:674. https:\/\/doi.org\/10.3389\/fnins.2019.00674","journal-title":"Front Neurosci"},{"key":"3796_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2013.02.008","volume":"47","author":"JW Kaspar","year":"2009","unstructured":"Kaspar JW, Niture SK, Jaiswal AK (2009) Nrf 2: INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47:1304\u20131309. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.02.008","journal-title":"Free Radic Biol Med"},{"key":"3796_CR26","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0963689717714102","volume":"26","author":"M Galgano","year":"2017","unstructured":"Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao L-R (2017) Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant 26:1118\u20131130. https:\/\/doi.org\/10.1177\/0963689717714102","journal-title":"Cell Transplant"},{"key":"3796_CR27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fphar.2020.00690","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Shi Z, You L, Du Y, Ni J, Yan D (2020) Neuroprotective effect of catalpol via anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. Front Pharmacol 11:690. https:\/\/doi.org\/10.3389\/fphar.2020.00690","journal-title":"Front Pharmacol"},{"key":"3796_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW (2019) Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci 13:528. https:\/\/doi.org\/10.3389\/fncel.2019.00528","journal-title":"Front Cell Neurosci"},{"key":"3796_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/ars.2012.4981","volume":"19","author":"C Cornelius","year":"2013","unstructured":"Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, Radak Z, Calabrese EJ, Cuzzocrea S (2013) Traumatic brain injury: oxidative stress and neuroprotection. Antioxid Redox Signal 19:836\u2013853. https:\/\/doi.org\/10.1089\/ars.2012.4981","journal-title":"Antioxid Redox Signal"},{"key":"3796_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2174\/0929867321666131217153310","volume":"21","author":"A Rodriguez-Rodriguez","year":"2014","unstructured":"Rodriguez-Rodriguez A, Jose Egea-Guerrero J, Murillo-Cabezas F, Carrillo-Vico A (2014) Oxidative stress in traumatic brain injury. Curr Med Chem 21:1201\u20131211. https:\/\/doi.org\/10.2174\/0929867321666131217153310","journal-title":"Curr Med Chem"},{"key":"3796_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pmr.2016.12.001","volume":"9","author":"V Di Pietro","year":"2020","unstructured":"Di Pietro V, Yakoub KM, Caruso G, Lazzarino G, Signoretti S, Barbey AK, Tavazzi B, Lazzarino G, Belli A, Amorini AM (2020) Antioxidant therapies in traumatic brain injury. Antioxidants 9:260. https:\/\/doi.org\/10.1016\/j.pmr.2016.12.001","journal-title":"Antioxidants"},{"key":"3796_CR32","doi-asserted-by":"publisher","first-page":"630222","DOI":"10.3389\/fphar.2020.630222","volume":"11","author":"H Xia","year":"2020","unstructured":"Xia H, Wang D, Guo X, Wu K, Huang F, Feng Y (2020) Catalpol protects against spinal cord injury in mice through regulating microRNA-142-mediated HMGB1\/TLR4\/NF-kappaB signaling pathway. Front Pharmacol 11:630222. https:\/\/doi.org\/10.3389\/fphar.2020.630222","journal-title":"Front Pharmacol"},{"key":"3796_CR33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R (2018) Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res 1865:721\u2013733. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.02.010","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3796_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2007.11.060","volume":"431","author":"W Yan","year":"2008","unstructured":"Yan W, Wang H-D, Hu Z-G, Wang Q-F, Yin H-X (2008) Activation of Nrf2\u2013ARE pathway in brain after traumatic brain injury. Neurosci Lett 431:150\u2013154. https:\/\/doi.org\/10.1016\/j.neulet.2007.11.060","journal-title":"Neurosci Lett"},{"key":"3796_CR35","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Singh TG, Kaur A (2021) Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. J Mol Neurosci 71:1725\u20131742. https:\/\/doi.org\/10.1007\/s12031-021-01841-7","journal-title":"J Mol Neurosci"},{"key":"3796_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/neu.2008.0655","volume":"26","author":"W Jin","year":"2009","unstructured":"Jin W, Wang H, Yan W, Zhu L, Hu Z, Ding Y, Tang K (2009) Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma 26:131\u2013139. https:\/\/doi.org\/10.1089\/neu.2008.0655","journal-title":"J Neurotrauma"},{"key":"3796_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72:355\u2013362. https:\/\/doi.org\/10.1001\/jamaneurol.2014.3558","journal-title":"JAMA Neurol"},{"key":"3796_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70:374\u2013383. https:\/\/doi.org\/10.1002\/ana.22455","journal-title":"Ann Neurol"},{"key":"3796_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/01.ta.0000196345.81169.a1","volume":"60","author":"K Kamm","year":"2006","unstructured":"Kamm K, VanderKolk W, Lawrence C, Jonker M, Davis AT (2006) The effect of traumatic brain injury upon the concentration and expression of interleukin-1\u03b2 and interleukin-10 in the rat. J Trauma 60:152\u2013157. https:\/\/doi.org\/10.1097\/01.ta.0000196345.81169.a1","journal-title":"J Trauma"},{"key":"3796_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neulet.2012.03.089","volume":"519","author":"J Rasouli","year":"2012","unstructured":"Rasouli J, Lekhraj R, White NM, Flamm ES, Pilla AA, Strauch B, Casper D (2012) Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury. Neurosci Lett 519:4\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2012.03.089","journal-title":"Neurosci Lett"},{"key":"3796_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","volume":"117","author":"X Xu","year":"2018","unstructured":"Xu X, Yin D, Ren H, Gao W, Li F, Sun D, Wu Y, Zhou S, Lyu L, Yang M (2018) Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 117:15\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.016","journal-title":"Neurobiol Dis"},{"key":"3796_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fphar.2017.00459","volume":"8","author":"N Irrera","year":"2017","unstructured":"Irrera N, Pizzino G, Cal\u00f2 M, Pallio G, Mannino F, Fam\u00e0 F, Arcoraci V, Fodale V, David A, Francesca C (2017) Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front Pharmacol 8:459. https:\/\/doi.org\/10.3389\/fphar.2017.00459","journal-title":"Front Pharmacol"},{"key":"3796_CR43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1460-9568.2009.06820","volume":"30","author":"F Clausen","year":"2009","unstructured":"Clausen F, H\u00e5nell A, Bj\u00f6rk M, Hillered L, Mir AK, Gram H, Marklund N (2009) Neutralization of interleukin-1\u03b2 modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 30:385\u2013396. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.06820","journal-title":"Eur J Neurosci"},{"key":"3796_CR44","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.3390\/ijms21176204","volume":"21","author":"N Irrera","year":"2020","unstructured":"Irrera N, Russo M, Pallio G, Bitto A, Mannino F, Minutoli L, Altavilla D, Squadrito F (2020) The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. Int J Mol Sci 21:6204. https:\/\/doi.org\/10.3390\/ijms21176204","journal-title":"Int J Mol Sci"},{"key":"3796_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020562","author":"P Hennig","year":"2018","unstructured":"Hennig P, Garstkiewicz M, Grossi S, Di Filippo M, French LE, Beer HD (2018) The crosstalk between Nrf2 and inflammasomes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19020562","journal-title":"Int J Mol Sci"},{"key":"3796_CR46","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.2147\/JIR.S334423","volume":"14","author":"M Ikram","year":"2021","unstructured":"Ikram M, Park HY, Ali T, Kim MO (2021) Melatonin as a potential regulator of oxidative stress, and neuroinflammation: mechanisms and implications for the management of brain injury-induced neurodegeneration. J Inflamm Res 14:6251. https:\/\/doi.org\/10.2147\/JIR.S334423","journal-title":"J Inflamm Res"},{"key":"3796_CR47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1089\/neu.2021.0466","volume":"39","author":"XJ Zhao","year":"2022","unstructured":"Zhao XJ, Zhu HY, Wang XL, Lu XW, Pan CL, Xu L, Liu X, Xu N, Zhang ZY (2022) Oridonin ameliorates traumatic brain injury-induced neurological damage by improving mitochondrial function and antioxidant capacity and suppressing neuroinflammation through the Nrf2 pathway. J Neurotrauma 39:530\u2013543. https:\/\/doi.org\/10.1089\/neu.2021.0466","journal-title":"J Neurotrauma"},{"key":"3796_CR48","doi-asserted-by":"publisher","first-page":"4717258","DOI":"10.1155\/2020\/4717258","volume":"2020","author":"J Yu","year":"2020","unstructured":"Yu J, Wang WN, Matei N, Li X, Pang JW, Mo J, Chen SP, Tang JP, Yan M, Zhang JH (2020) Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK\/Nrf2\/TXNIP pathway after MCAO in rats. Oxid Med Cell Longev 2020:4717258. https:\/\/doi.org\/10.1155\/2020\/4717258","journal-title":"Oxid Med Cell Longev"},{"key":"3796_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2017.06.027","volume":"336","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang Y, He Q, Li L, Xie H, Zhao Y, Zhao J (2018) Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1\/TXNIP complex in cerebral ischemia reperfusion injury. Behav Brain Res 336:32\u201339. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.027","journal-title":"Behav Brain Res"},{"key":"3796_CR50","doi-asserted-by":"publisher","first-page":"628209","DOI":"10.3389\/fphar.2021.628209","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ji J, Zha Z, Zhao H, Xue B, Jin L, Wang L (2021) Effect and mechanism of catalpol on remyelination via regulation of the NOTCH1 signaling pathway. Front Pharmacol 12:628209. https:\/\/doi.org\/10.3389\/fphar.2021.628209","journal-title":"Front Pharmacol"},{"key":"3796_CR51","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.11.101","author":"J Wang","year":"2019","unstructured":"Wang J, Wan D, Wan G, Wang J, Zhang J, Zhu H (2019) Catalpol induces cell activity to promote axonal regeneration via the PI3K\/AKT\/mTOR pathway in vivo and in vitro stroke model. Ann Transl Med. https:\/\/doi.org\/10.21037\/atm.2019.11.101","journal-title":"Ann Transl Med"},{"key":"3796_CR52","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.biopha.2018.04.156","volume":"103","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhu P, Zhang L, Xiong B, Tao J, Guan W, Li C, Chen C, Gu J, Duanmu J, Zhang W (2018) Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis. Biomed Pharmacother 103:1262\u20131271. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.156","journal-title":"Biomed Pharmacother"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03796-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03796-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T11:36:09Z","timestamp":1675251369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03796-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3796"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03796-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was reviewed and approved by the Soochow University Institutional Animal Care and Use Committee (NO. ZJGYYLL-2021\u201309-008; Date: 7 Sep., 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Appoval"}}]}}